Tsuruga Y, Kiyono T, Matsushita M, Takahashi T, Kasai N, Matsumoto S, Todo S
Department of General Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Transplant Proc. 2008 Mar;40(2):617-9. doi: 10.1016/j.transproceed.2008.02.007.
We have established immortalized human hepatocytes by transduction of HPV16 E6/E7 and hTERT (HHE6E7T-1). The cells retained the characteristics of differentiated hepatocytes, but the functional characteristics such as albumin secretion, ureogenesis, and glyconeogenesis decreased gradually as the passages progressed beyond 200 population doublings (PDs). In this report, we transplanted minimally differentiated HHE6E7T-1 cells into the spleens of acute liver failure severe combined immunodeficiency (SCID) mice to examine the potential of the cells to redifferentiate in vivo.
Acute liver failure was induced in SCID mice by intraperitoneal injection of 400 mg/kg acetaminophen. Two hours later, HHE6E7T-1 cells at 200 PDs were transplanted: group 1 (n = 10) 50 microL phosphate-buffered saline (PBS); group 2 (n = 9), lysate of 1 x 10(6) HHE6E7T-1 cells at 200 PDs resuspended in 50 microL PBS; and group 3 (n = 8), 1 x 10(6) HHE6E7T-1 cells. Survival rates at 7 days after transplantation were compared. Blood glucose levels, plasma ammonia levels, and spleen histology were examined at 24 hours after transplantation.
Survivals in each group were: 30% for group 1, 33% for group 2, and 100% for group 3. The survival of group 3 was significantly higher than groups 1 or 2 (P < .01). Plasma ammonia levels in group 3 (200 +/- 34 microg/dL) were significantly lower than those in group 1 (325 +/- 92 microg/dL; P < .05). Blood glucose levels in group 3 (110 +/- 20 mg/dL) were significantly higher than those in group 1 (83 +/- 14 mg/dL; P < .05). Upon histologic examination of spleen, the clusters of HHE6E7T-1 cells were clearly identified.
The immortalized human hepatocytes, HHE6E7T-1 at 200 PDs, improved the survival of acute liver failure mice through possible redifferentiation in vivo.
我们通过转导人乳头瘤病毒16 E6/E7和人端粒酶逆转录酶(hTERT)建立了永生化人肝细胞系(HHE6E7T-1)。这些细胞保留了分化肝细胞的特征,但随着传代超过200次群体倍增(PDs),其白蛋白分泌、尿素生成和糖异生等功能特征逐渐下降。在本报告中,我们将低分化的HHE6E7T-1细胞移植到急性肝衰竭重症联合免疫缺陷(SCID)小鼠的脾脏中,以研究这些细胞在体内重新分化的潜力。
通过腹腔注射400 mg/kg对乙酰氨基酚诱导SCID小鼠发生急性肝衰竭。两小时后,移植200 PDs的HHE6E7T-1细胞:第1组(n = 10)注射50 μL磷酸盐缓冲盐水(PBS);第2组(n = 9),将1×10⁶个200 PDs的HHE6E7T-1细胞的裂解物重悬于50 μL PBS中;第3组(n = 8),注射1×10⁶个HHE6E7T-1细胞。比较移植后7天的存活率。移植后24小时检测血糖水平、血浆氨水平和脾脏组织学。
每组的存活率分别为:第1组30%,第2组33%,第3组100%。第3组的存活率显著高于第1组或第2组(P <.01)。第3组的血浆氨水平(200±34 μg/dL)显著低于第1组(325±92 μg/dL;P <.05)。第3组的血糖水平(110±20 mg/dL)显著高于第1组(83±14 mg/dL;P <.05)。对脾脏进行组织学检查时,可清晰识别出HHE6E7T-1细胞簇。
200 PDs的永生化人肝细胞HHE6E7T-1可能通过在体内重新分化提高了急性肝衰竭小鼠的存活率。